Cancer Pain

Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances

Cancer Patients Treated With Step III Opioids Often Have Sleep Disturbances

By

The majority of patients with cancer who are being treated with World Health Organization Step III opioids were found to experience poor sleep quality, often due to pain.

Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer

Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer

In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.

Senior Patients With Bone Metastasis Also Benefit From Palliative Radiotherapy

Senior Patients With Bone Metastasis Also Benefit From Palliative Radiotherapy

All patients with painful bone metastasis should be referred for palliative radiotherapy to relieve the pain, regardless of age.

Pediatric Chemotherapy May Be Associated With Long-Term Peripheral Neuropathy

Pediatric Chemotherapy May Be Associated With Long-Term Peripheral Neuropathy

By

Childhood cancer survivors are at risk for long-term peripheral neuropathy, particularly when treated with cisplatin.

Art Intervention Clinically Effective in Treating Cancer-Related Pain, Mood Symptoms

Art Intervention Clinically Effective in Treating Cancer-Related Pain, Mood Symptoms

By

Art-based interventions could be easily implemented as an adjunct to conventional therapies for cancer-related pain and mood symptoms.

Cryoablation Efficacious for Cancer Pain, Review Finds

Cryoablation Efficacious for Cancer Pain, Review Finds

Researchers conducted a systematic literature review to identify articles that evaluated the efficacy of cryoablation to control cancer pain.

Many Oncologists Discuss, Recommend Medical Marijuana

Many Oncologists Discuss, Recommend Medical Marijuana

Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility.

Despite Research Gap, Medical Marijuana Use Supported at End of Life in Pediatric Cancer

Despite Research Gap, Medical Marijuana Use Supported at End of Life in Pediatric Cancer

By

Since the legalization of medical marijuana, clinicians must come up with appropriate responses to requests for treatment in pediatric end-of-life settings.

Nitrous Oxide/Oxygen Mixture as Adjunct to Morphine May Provide Relief From Breakthrough Cancer Pain

Nitrous Oxide/Oxygen Mixture as Adjunct to Morphine May Provide Relief From Breakthrough Cancer Pain

By

Self-administration of a nitrous oxide/oxygen mixture may be more effective than oxygen alone as an adjunct analgesic treatment in reducing moderate to severe breakthrough cancer pain.

Opioid Epidemic Response May Restrict Cancer-Related Pain Management

Opioid Epidemic Response May Restrict Cancer-Related Pain Management

Although much of the response to the opioid epidemic exempts treatment for cancer-related pain, a recent Oncology Nurse Advisor online survey showed that more than 80% of respondents were concerned about how current restrictions set up to manage the opioid crisis are affecting cancer patient pain management.

Chemo-Induced Peripheral Neuropathy Risk Reduced With Multivitamin

Chemo-Induced Peripheral Neuropathy Risk Reduced With Multivitamin

Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy.

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

By

The FDA recommended the approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL).

WHO Updates, Revises Essential Medicines List

WHO Updates, Revises Essential Medicines List

By

WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.

Preclinical Pain as a Marker for Amyotrophic Lateral Sclerosis

Preclinical Pain as a Marker for Amyotrophic Lateral Sclerosis

By

Pain is far more common and widespread in ALS than previously suspected, and initial pain symptoms may predate the clinical onset of the disease's hallmark motor dysfunction by as much as 2 years.

Updated Guideline for Palliative Radiotherapy for Bone Metastases

Updated Guideline for Palliative Radiotherapy for Bone Metastases

By

A guideline update from the American Society for Radiation Oncology continues to support the efficacy and safety of palliative radiation therapy for bone metastases.

Sublingual Fentanyl Preferred, But Less Effective Than Subcutaneous Morphine

Sublingual Fentanyl Preferred, But Less Effective Than Subcutaneous Morphine

By

Fentanyl sublingual tablets are preferred over subcutaneous morphine in patients with severe breakthrough cancer pain.

Underprescription of Opioids in Cancer Patients During End of Life

Underprescription of Opioids in Cancer Patients During End of Life

By

Although opioids are considered a first-line treatment for late-stage cancer pain, they are often prescribed relatively late and for only a short duration before death in many patients.

Breakthrough Cancer Pain With Lazanda at New Dosage

Breakthrough Cancer Pain With Lazanda at New Dosage

By

Depomed has announced that Lazanda (fentanyl) nasal spray, CII, is now available at 300mcg dose strength to treat cancer pain.

Guidance for Treatment Selection for Severe, Refractory Chronic Pain

Guidance for Treatment Selection for Severe, Refractory Chronic Pain

By

Intrathecal therapy represents a valuable option for many patients with severe, refractory chronic pain.

Medical Marijuana Laws May Reduce Medicare Prescription Use, Spending

Medical Marijuana Laws May Reduce Medicare Prescription Use, Spending

By

In states where marijuana is legalized for medicinal purposes, Medicare's prescription drug benefit program has lowered its spending due to reduced prescription drug use.

Interventional Treatments of Cancer Pain are Effective but Under-Utilized

Interventional Treatments of Cancer Pain are Effective but Under-Utilized

By

Interventional Treatment Options for Cancer Pain

American Pain Society to Host 35th Annual Scientific Meeting

American Pain Society to Host 35th Annual Scientific Meeting

The American Pain Society next month will be welcoming pain researchers to its 35th Annual Scientific Meeting. Attendees can expect an array of educational sessions focusing on acute pain, chronic cancer and noncancer pain, and recurrent pain.

Rethinking Strong Opioids for Noncancer Pain

Rethinking Strong Opioids for Noncancer Pain

By

Are we overestimating the efficacy of step III analgesics?

Guided Meditation Reduces Pain During Breast Biopsy

Guided Meditation Reduces Pain During Breast Biopsy

By

Patients who listened to guided meditation or music during their biopsy reported significantly greater reductions in anxiety and fatigue than standard care.

Calmare: A Potential Option for Neuropathic Cancer Pain

Calmare: A Potential Option for Neuropathic Cancer Pain

By

Calmare therapy may be an effective option for treating cancer-related neuropathic pain.

Families Prefer Hospice Over Hospital for Relatives Dying From Cancer

Families Prefer Hospice Over Hospital for Relatives Dying From Cancer

Earlier hospice enrollment important area to focus on to improve the quality of end-of-life cancer care.

Lower Hospital Costs Tied to Palliative Care Consult

Lower Hospital Costs Tied to Palliative Care Consult

Greater cost savings for cancer patients with more comorbidities.

Aspirin Use Linked to Lower Risk of Lethal Prostate Cancer, Study Shows

Aspirin Use Linked to Lower Risk of Lethal Prostate Cancer, Study Shows

Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis.

New Insight on the Role of Aspirin in Breast Cancer

New Insight on the Role of Aspirin in Breast Cancer

Two new studies shed more light on whether of aspirin can help treat breast cancer patients.

Time to Treatment Initiation Impacts Survival in Head, Neck Cancer

Time to Treatment Initiation Impacts Survival in Head, Neck Cancer

Lower overall survival for time to treatment initiation of more than 46 to 52 days.

Sign Up for Free e-Newsletters